DK1171144T3 - Anvendelse af tetrahydrocurcuminoider til regulering af fysiologiske og patologiske forhold i huden og slimhinderne - Google Patents

Anvendelse af tetrahydrocurcuminoider til regulering af fysiologiske og patologiske forhold i huden og slimhinderne

Info

Publication number
DK1171144T3
DK1171144T3 DK00921582T DK00921582T DK1171144T3 DK 1171144 T3 DK1171144 T3 DK 1171144T3 DK 00921582 T DK00921582 T DK 00921582T DK 00921582 T DK00921582 T DK 00921582T DK 1171144 T3 DK1171144 T3 DK 1171144T3
Authority
DK
Denmark
Prior art keywords
tetrahydrocurcuminoids
physiological
regulation
skin
pathological conditions
Prior art date
Application number
DK00921582T
Other languages
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
Original Assignee
Sabinsa Corp
Sami Chemicals And Extracts P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sabinsa Corp, Sami Chemicals And Extracts P filed Critical Sabinsa Corp
Application granted granted Critical
Publication of DK1171144T3 publication Critical patent/DK1171144T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK00921582T 1999-04-09 2000-04-07 Anvendelse af tetrahydrocurcuminoider til regulering af fysiologiske og patologiske forhold i huden og slimhinderne DK1171144T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12854099P 1999-04-09 1999-04-09
PCT/US2000/008711 WO2000061162A1 (en) 1999-04-09 2000-04-07 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa

Publications (1)

Publication Number Publication Date
DK1171144T3 true DK1171144T3 (da) 2007-06-11

Family

ID=22435823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00921582T DK1171144T3 (da) 1999-04-09 2000-04-07 Anvendelse af tetrahydrocurcuminoider til regulering af fysiologiske og patologiske forhold i huden og slimhinderne

Country Status (11)

Country Link
EP (1) EP1171144B1 (da)
JP (1) JP2002541205A (da)
AT (1) ATE353662T1 (da)
AU (1) AU4187900A (da)
CA (1) CA2369381A1 (da)
DE (1) DE60033383T2 (da)
DK (1) DK1171144T3 (da)
ES (1) ES2282101T3 (da)
NZ (1) NZ514884A (da)
PT (1) PT1171144E (da)
WO (1) WO2000061162A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653327B2 (en) * 1999-04-09 2003-11-25 Sabinsa Corporation Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays
US6521668B2 (en) * 1999-12-14 2003-02-18 Avon Products, Inc. Cosmetic composition and methods of use
DE10121089A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und Substanzen, die verhindern, dass die NO-Synthase des warmblütigen Organismus seine Wirkung entfaltet
DE10121069A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut
DE10121090A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und Sericosid und/oder Pflanzenextrakten
DE10121070A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zur Anregung der Ceramid-Biosynthese der Haut
DE10121093A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zur Verbesserung der Barrierefunktion der Haut
DE10121067A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Kombination von Tetrahydrocurcuminoiden oder deren Derivaten mit 3-[4-Hydroxyphenylsulfatester]-2-Aminopropionsäure oder 3-[3-Hydroxyphenylsulfatester]-2-Aminopropionsäure (Tyrosin O-Sulfatester) oder entsprechende Sulfonsäureester oder Phosphatester oder ihre Derivate sowie ihre pflanzlichen und tierischen Extrakte als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zur Haufaufhellung oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
EP2370069B1 (en) * 2008-11-26 2020-09-30 Perio Sciences, LLC Antioxidant compositions for soft oral tissue and methods of formulation and use thereof
CA2849910A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
FR2983402B1 (fr) * 2011-12-05 2013-12-20 Oreal Composition de coloration capillaire, comprenant un tetrahydrocurcuminoide, un colorant capillaire et un mono-alcool liquide
CN106266988A (zh) * 2016-09-12 2017-01-04 四川聚豪生物科技有限公司 一种用于治疗气瘿的中药组合物及其制备方法
JP2021023147A (ja) * 2019-07-31 2021-02-22 ハウス食品株式会社 グルコース酸化物生成抑制用組成物、ＡＧＥｓ生成抑制用組成物、及び、ＡＧＥｓを介したタンパク質分子間の架橋の切断用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0249747A (ja) * 1988-08-12 1990-02-20 Kobe Steel Ltd 抗酸化剤
JPH06128133A (ja) * 1992-10-20 1994-05-10 Kobe Steel Ltd 紫外線障害防御外用剤
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
EP0839037B1 (en) * 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids

Also Published As

Publication number Publication date
ES2282101T3 (es) 2007-10-16
DE60033383D1 (de) 2007-03-29
EP1171144B1 (en) 2007-02-14
ATE353662T1 (de) 2007-03-15
CA2369381A1 (en) 2000-10-19
JP2002541205A (ja) 2002-12-03
AU4187900A (en) 2000-11-14
NZ514884A (en) 2008-05-30
PT1171144E (pt) 2007-04-30
WO2000061162A9 (en) 2001-11-29
WO2000061162A1 (en) 2000-10-19
DE60033383T2 (de) 2007-05-31
EP1171144A1 (en) 2002-01-16

Similar Documents

Publication Publication Date Title
DK1171144T3 (da) Anvendelse af tetrahydrocurcuminoider til regulering af fysiologiske og patologiske forhold i huden og slimhinderne
DK0927150T3 (da) Lipoxinforbindelser og deres anvendelse til behandling af celleformeringsforstyrrelser
NZ335981A (en) Ketobenzamides as calpain inhibitors
WO2002032415A3 (en) Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
DK130387D0 (da) Transglutaminase inhibitorer
DE3280344D1 (de) Verwendung von retinoiden und minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxid) zur verbesserung des wachstums von menschlichem kopfhaar und zur behandlung bestimmter typen von alopecia.
EP0288534A4 (en) COMPOSITIONS OF CATECHOLIC BUTANES WITH ZINC.
DE69725293D1 (de) N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität
WO1999046279A3 (en) INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
FR2816838B1 (fr) Utilisation de derives de l'acide 2-oxothiazolidine- 4-carboxylique comme agents prodesquamants
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
EP0786995A4 (da)
DE3780618T2 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
SE9303788D0 (sv) Biomedicinsk elektrod
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
ZA951784B (en) Utilisation des acides sulfoniques comme agents antivicillissement dans une composition cosmetique ou dermatologique
IT8567714A1 (it) Procedimento enzimatico di depilazione di pelli.
DE69900160D1 (de) Harnstoff enthaltende Zusammensetzung und ihre kosmetische und dermatologische Verwendung
PL353035A1 (en) Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
DK23392D0 (da) Heterocykliske forbindelser, deres anvendelse og fremstilling
EP0167288A3 (en) 4-(2-(N,N-disubstituted-amino)ethyl]isatins
AP2000002004A0 (en) Method of treatment for dermatological disorders and compositions therefor.
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
ES8106156A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona